Accustem Sciences (ACUT, $0.24) was a top loser over the last three months, falling -2 to $0.24 per share. A.I.dvisor analyzed 849 stocks in the Biotechnology Industry for the 3-month period ending February 20, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.